Rho B Inhibitors belong to a significant class of compounds that hold a crucial place in cellular research due to their distinct properties and interactions. These inhibitors target the Rho B protein, which is a member of the Rho family of small GTPases. Rho proteins play a pivotal role in regulating various cellular processes, including cytoskeletal dynamics, cell migration, and cell adhesion. Specifically, Rho B is involved in controlling actin dynamics and modulating cellular morphology. Rho B Inhibitors are designed to interfere with the activity of the Rho B protein, thereby influencing these fundamental cellular mechanisms. Structurally, Rho B Inhibitors often feature a core scaffold that interacts with the active site of the Rho B protein, thereby preventing its normal signaling cascade. Researchers have extensively explored the molecular interactions between these inhibitors and Rho B to gain insights into their mechanism of action. By inhibiting the function of Rho B, these compounds can disrupt the intricate network of cellular pathways that rely on Rho GTPases for their proper execution.
Studies involving Rho B Inhibitors have contributed to a deeper understanding of cellular processes that rely on Rho GTPases, shedding light on the intricate regulatory mechanisms that govern cell morphology, migration, and adhesion. Through their targeted inhibition of Rho B, these compounds have enabled researchers to dissect the specific roles of this protein in various biological contexts. This knowledge has implications for our understanding of fundamental cell biology and could lead to the development of novel approaches for modulating cellular behavior. In conclusion, Rho B Inhibitors constitute an important class of compounds that play a significant role in cellular research. By selectively targeting the Rho B protein and disrupting its function, these inhibitors provide valuable insights into the intricate cellular processes that rely on Rho GTPase signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a widely studied Rho-associated protein kinase (ROCK) inhibitor. It is known for its ability to inhibit Rho kinase activity and has been used to study various cellular processes involving Rho signaling. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Fasudil is another ROCK inhibitor that has been used for its vasodilatory effects. It has shown potential in conditions like cerebral vasospasm and pulmonary hypertension. | ||||||
GSK 429286 | 864082-47-3 | sc-361200 sc-361200B sc-361200A | 1 mg 5 mg 10 mg | $40.00 $125.00 $235.00 | ||
This compound is a potent and selective Rho kinase inhibitor. It has been used in research to study the role of Rho signaling in various biological processes. | ||||||
RKI-1447 | 1342278-01-6 | sc-472590 | 1 mg | $330.00 | ||
RKI-1447 is a potent inhibitor of ROCK. It has shown promise in research studies for its potential in cancer by inhibiting cancer cell migration and invasion. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Rhosin is a small molecule inhibitor that specifically targets Rho GTPases. It interferes with Rho activity and has been used to study the role of Rho GTPases in various cellular functions. | ||||||